温馨提示:本站仅提供公开网络链接索引服务,不存储、不篡改任何第三方内容,所有内容版权归原作者所有
AI智能索引来源:http://www.poz.com/tag/cure
点击访问原文链接

The Search for the Cure - POZ

POZ DirectoryMy AccountHomeBasicsBasicsIntroductionHIV Transmission and RisksHIV TestingHIV PreventionNewly DiagnosedStarting HIV TreatmentHIV MedicationsHIV Drug Assistance ProgramsOther Related ConditionsVIH/SIDA en EspañolNewsNewsNewsfeedScience NewsFeaturesOpinionsConferencesSlideshowsVideosPOZ at HomePOZ TVPOZ StoriesPOZ 100By AuthorRSS LinksHot TopicsHot TopicsPOZ AwardsWorld AIDS DayCriminalizationCureLong-Term SurvivorsNewly DiagnosedPrEPPreventionUndetectable (U=U)YouthMagazineMagazineCurrent IssueArchivesDigital EditionsPOZ FocusPOZ en EspañolSubscriptionsEmail NewslettersBlogsBlogsRecent PostsBrowse BloggersRSS LinksCommunityCommunityPOZ PersonalsPOZ StoriesPOZ 100CommunityAIDS Is EverydayForumsPollsSurveysQuizzesAsk POZAwareness DaysServices DirectoryCalendarJobsBookstoreAbout UsAbout UsAbout UsMastheadAwardsPress ReleasesAdvertiseContact UsSmart + StrongTerms of useYour privacySmart + StrongSmart + StrongTerms of useYour privacySmart + StrongTwo More People May Be Cured of HIV After Stem Cell Transplants#Prevention#PrEPTwo More People May Be Cured of HIV After Stem Cell Transplants#Prevention#PrEPGalleri, a Blood Test to Detect Over 50 Cancers, Misses the Mark in Clinical TrialThe multi-cancer blood test failed to reduce late-stage diagnoses; trial results don’t support the test’s rollout, says an expert.Dual Immunotherapy Delays—but Does Not Prevent—HIV ReboundPD-1 immune checkpoint inhibitors are among the many approaches being studied in HIV cure research.ConferencesResearchers Describe Exceptional Elite Controller in SpainAnother woman may have naturally eliminated intact HIV without antiretroviral treatment.On Christmas Eve 2012, Kyle Clifford Learned He Had HIV. Now He’s Leading AIDS ResearchWatch a hopeful message from Kyle Clifford, the incoming CEO of amfAR, The Foundation for AIDS Research.Researchers See Dramatic Drop in HIV-Infected Immune Cells After Cancer TreatmentStudy by Johns Hopkins Medicine-led team suggests finding may be an early step toward a potential HIV cure.#Long-Term Survivors#Life Expectancy#Newly DiagnosedCombination Immunotherapy May Help T Cells Fight HIVAn HIV vaccine plus broadly neutralizing antibodies and an immune-stimulating drug helped control HIV after stopping antiretrovirals.New Study Identifies Key Mechanism Driving HIV-Associated Immune SuppressionReducing overactive plasmacytoid dendritic cells helped restore antiviral T-cell function and shrink the viral reservoir.Clues to a Cure: Next Berlin Patient Has Powerful Natural Killer CellsThe man’s highly efficient immune response may have helped eliminate residual HIV after a stem cell transplant.amfAR Awards New HIV Cure-Focused Research Grants Totaling $2.4MHigh number of applications for amfAR’s Target Grants shows fierce competition for HIV research funding. [VIDEO]Women May Naturally Control HIV Better Than MenWomen may be better candidates for functional cure strategies that aim to prevent viral rebound after stopping antiretrovirals.HIV: The BasicsAsk POZIAS Conference Content Now Available to AllEveryone can now view recorded sessions from the International AIDS Society Conference on HIV Science in July.Bolstering HIV Cure Research in the Current Political Context: A Statement from The Well Project and the Women’s Research Initiative on HIV/AIDSDespite four decades of advances in HIV research, advocacy, treatment, and prevention, an HIV cure remains essential.New Center for HIV Cure ResearchWistar is a top independent nonprofit.Broadly Neutralizing Antibodies Plus Anktiva May Delay HIV ReboundAnktiva, an IL-15 superagonist approved for bladder cancer treatment, may help maintain viral control after stopping antiretrovirals.Novel mRNA Technology Coaxes HIV Out of HidingForcing inactive virus in CD4 cells to reveal itself could facilitate a functional cure.Study Finds Racial Disparities in HIV Rates Among Transgender WomenComprehensive National PrEP Bills to Prevent HIV IntroducedFlorida ADAP Consumers: Special Enrollment Period Now Open Through MarketplaceGalleri, a Blood Test to Detect Over 50 Cancers, Misses the Mark in Clinical TrialNMAC Responds to Drastic Changes to Florida ADAPPipeline Drugs Could Allow for Twice-Yearly HIV TreatmentDoravirine/Islatravir Combo Pill Could Soon Be a New HIV Treatment OptionBroadly Neutralizing Antibody Helps Maintains Viral SuppressionBictegravir/Lenacapavir Combo Pill Could Replace Complex HIV TreatmentOral Cancer Is Rising Among People With HIVSupplements Don’t Prevent Cancer, Studies ShowTrump’s Cuts to Medicaid Threaten Services That Help Disabled People Live at HomeState Lawmakers Seek Restraints on Wage Garnishment for Medical DebtThe Promise: A Final Interview With Butch McKayWhen It Comes to Health Insurance, Federal Dollars Support More Than ACA PlansThe Ever-Shrinking Eldercare WorkforceACTION ALERT: Urge the House to Pass 2026 Spending Bill to Fund HIV ProgramsFour Decades In, Black Communities Are Still Paying the Highest Price from HIVAfter Mulling Extreme Cuts, Congress Funds Domestic HIV ProgramsGood and Bad News About the New Dietary Guidelines for AmericansClick hereOur Privacy PolicyManagePrivacy PolicyCookie Usage

智能索引记录